BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2020
View Archived Issues
Enrollment completed and interim data presented from DRIIV-1b study of AsiDNA
Read More
Kira secures investments to advance development of novel complement-targeted therapies
Read More
Curasight initiates preclinical study of uTREAT therapy in brain cancer
Read More
First patient treated in phase I study of MaaT-033
Read More
Medshine Discovery divulges KLKB1 inhibitors
Read More
HitGen patents HDAC inhibitors
Read More
Enrollment completed in phase III study of Covishield in India
Read More
Epitas Biosciences presents IDH2 inhibitors
Read More
Betta Pharmaceuticals synthesizes new KRAS mutant inhibitors
Read More
Shanghai Public Utilities Institute patents antibodies for SARS-CoV-2 infection
Read More
Sharing without oversharing: Quick-ish cleanup can preserve privacy in functional genomics datasets
Read More
Safety, pharmacology and preliminary efficacy of VT-1021 in patients with advanced solid tumors
Read More
First patient dosed in phase II study of tomivosertib plus chemotherapy in breast cancer
Read More
FDA allows IND application for AV-001 in hospitalized patients with COVID-19
Read More
BVX-0320 vaccine candidate shows promising preclinical efficacy against SARS-CoV-2
Read More
[124I]-RmAb158-scFv8D3 detects soluble Abeta changes following treatment
Read More
Selva begins phase I study with SLV-213 to treat COVID-19
Read More
Navidea reports further phase IIb data on Tc99m tilmanocept imaging for rheumatoid arthritis
Read More
Verrica reports phase II topline data on VP-102 for external genital warts
Read More
Denali achieves biomarker proof of concept for transport vehicle technology with DNL-310
Read More
Medicago's adjuvanted COVID-19 vaccine candidate advances into phase II/III
Read More
Trinomab cleared to begin phase I study in Australia with anti-tetanus toxin monoclonal antibody
Read More
Orchard presents new HSC gene therapy research programs in dementia and Crohn's disease
Read More